| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/20/2002 | CA2216129C Lactam-containing hydroxamic acids |
| 08/20/2002 | CA2073983C Novel vitamin d analogues |
| 08/20/2002 | CA2062653C Promotion of wound-healing with 15-keto-prostaglandin compounds |
| 08/20/2002 | CA2046485C An agent for tyrosinase inhibition |
| 08/15/2002 | WO2002063308A2 Prediction of wound healing by urinary nitrate assay |
| 08/15/2002 | WO2002063006A2 Receptors and membrane-associated proteins |
| 08/15/2002 | WO2002062970A1 Enteric nervous system derived stem and progenitor cells and uses thereof |
| 08/15/2002 | WO2002062804A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 08/15/2002 | WO2002062801A1 Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine a3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating glaucoma and method of lowering ocular tension |
| 08/15/2002 | WO2002062800A1 Bicyclic nitrogenous fused-ring compound |
| 08/15/2002 | WO2002062799A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents |
| 08/15/2002 | WO2002062798A2 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose |
| 08/15/2002 | WO2002062792A1 Jnk inhibitor |
| 08/15/2002 | WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/15/2002 | WO2002062784A1 Piperidinee derivatives as neurokinin 1 antagonists |
| 08/15/2002 | WO2002062780A2 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands |
| 08/15/2002 | WO2002062778A2 Anti-thrombotic compounds, production and use thereof as medicaments |
| 08/15/2002 | WO2002062776A1 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors |
| 08/15/2002 | WO2002062762A2 Potassium channel openers |
| 08/15/2002 | WO2002062761A1 Aminal diones as potassium channel openers |
| 08/15/2002 | WO2002062751A1 Novel cystine derivatives and inhibitors for the activation of inflammatory factors |
| 08/15/2002 | WO2002062750A1 Cannabinoid receptor ligands |
| 08/15/2002 | WO2002062748A1 Carboxylic amides, the production and use thereof as medicaments |
| 08/15/2002 | WO2002062422A1 Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof |
| 08/15/2002 | WO2002062403A1 A medical dressing comprising an antimicrobial silver compound |
| 08/15/2002 | WO2002062373A2 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 08/15/2002 | WO2002062365A1 Process for producing lamiacea plant extract containing phenols and use thereof |
| 08/15/2002 | WO2002062362A2 Antiviral and antibacterial composition |
| 08/15/2002 | WO2002062361A1 Antiviral composition containing propolis and essential oils |
| 08/15/2002 | WO2002062358A1 Cell suspension preparation technique and device |
| 08/15/2002 | WO2002062353A1 Composition containing sucrafate and a topical anesthetic for human and animals and method of use thereof |
| 08/15/2002 | WO2002062331A1 Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damaging cutaneous tissue |
| 08/15/2002 | WO2002062323A2 Use of mglur5 antagonists for the treatment of pruritic conditions |
| 08/15/2002 | WO2002062310A1 Multifunctional particulate additive for personal care and cosmetic compositions, and the process of making the same |
| 08/15/2002 | WO2002062306A1 Nos inhibitors for treatment of wrinkles |
| 08/15/2002 | WO2002062301A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails |
| 08/15/2002 | WO2002062135A2 Scce modified transgenic mammals and their use as models of human disease |
| 08/15/2002 | WO2002050101A8 Retinoblastoma-binding protein |
| 08/15/2002 | WO2002045800A3 Liquid composition comprising an alcohol |
| 08/15/2002 | WO2002034753A3 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 08/15/2002 | WO2002032861A3 Orally active salts with tyrosine kinase activity |
| 08/15/2002 | WO2002028866A3 Hydroxyesters of 7-desmethylrapamycin |
| 08/15/2002 | WO2002028434A3 Use of a ppar delta activator for treating inflammatory conditions |
| 08/15/2002 | WO2002028433A3 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition |
| 08/15/2002 | WO2002026729A3 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/15/2002 | WO2002024609A3 Method for producing a radioprotector |
| 08/15/2002 | WO2002022212A8 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 08/15/2002 | WO2002016381B1 Composition and method for inhibiting platelet aggregation |
| 08/15/2002 | WO2002000195A3 Methods and compositions for treating pain of the mucous membrane |
| 08/15/2002 | WO2001057079A3 C1 inhibitor produced in the milk of transgenic mammals |
| 08/15/2002 | WO2001034168A9 Inhibition of pathogens by bacillus coagulans strains |
| 08/15/2002 | WO2001032222A9 Selective toxin expression in angiogenic endothelial cells |
| 08/15/2002 | WO2001027135A9 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 08/15/2002 | US20020111493 Amidino compounds useful as nitric oxide synthase inhibitors |
| 08/15/2002 | US20020111353 Antiinflammatory agents; central nervous system disorders;antidiabgetic agents; rheumatic disorders |
| 08/15/2002 | US20020111336 Topical composition |
| 08/15/2002 | US20020111315 Synergistic mixture with antilipemic agent |
| 08/15/2002 | US20020111294 Administering an organocobalt complex |
| 08/15/2002 | US20020111290 Calibration of chemokine or receptor expression; medical diagnosis |
| 08/15/2002 | US20020110895 Nucleotide sequences coding enzymatic polypeptide for use in treatment of thrombosis and in the immune defects |
| 08/15/2002 | US20020110889 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/15/2002 | US20020110868 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 08/15/2002 | US20020110858 Lymphocytic membrane proteins |
| 08/15/2002 | US20020110853 Polypeptide; for use in the treatment of tumors |
| 08/15/2002 | US20020110840 Detecting modulators of interferon generation; obtain cells, incubate with modulator, monitor concentration of inflammatory cytokine, amplified cytokine concentration indicates modulators |
| 08/15/2002 | US20020110608 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 08/15/2002 | US20020110558 For therapy |
| 08/15/2002 | CA2437571A1 Receptors and membrane-associated proteins |
| 08/15/2002 | CA2437437A1 Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, pharmaceutical, composition adenosine a3 receptor affinitive agent, intraocular-pressure reducing agent, pharmaceutical preparation for prevention and treatment of glaucoma, and intraocular-pressure reducing method |
| 08/15/2002 | CA2437405A1 Potassium channel openers |
| 08/15/2002 | CA2437400A1 Aminal diones as potassium channel openers |
| 08/15/2002 | CA2437260A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 08/15/2002 | CA2437248A1 Jnk inhibitor |
| 08/15/2002 | CA2436837A1 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
| 08/15/2002 | CA2436741A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents |
| 08/15/2002 | CA2436738A1 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose |
| 08/15/2002 | CA2436465A1 Prediction of wound healing by urinary nitrate assay |
| 08/15/2002 | CA2435844A1 Method and composition for rejuvinating cells, tissues, organs, hair and nails |
| 08/15/2002 | CA2435820A1 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands |
| 08/15/2002 | CA2435620A1 Enteric nervous system derived stem and progenitor cells and uses thereof |
| 08/15/2002 | CA2435492A1 Antithrombotic compounds, the preparation thereof and their use as pharmaceutical compositions |
| 08/15/2002 | CA2434079A1 Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damaging cutaneous tissue |
| 08/14/2002 | EP1231213A1 Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical and alimentary fields |
| 08/14/2002 | EP1230952A2 Combinations of estrogen and progestogen for preventing and treating skin aging |
| 08/14/2002 | EP1230933A1 Remedies for intractable wound |
| 08/14/2002 | EP1230929A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
| 08/14/2002 | EP1230926A1 Skin-care agents, skin antiaging agents, whitening agents and external skin preparations |
| 08/14/2002 | EP1230924A1 Remedies for pigmentation and melanocyte proliferation inhibitors |
| 08/14/2002 | EP1230923A1 Tocotrienols as inhibitors for neovascularisation, cell multiplication, lumen formation and fgf |
| 08/14/2002 | EP1230919A2 Use of a composition comprising a retinoid and an erb inhibitor in the preparation of a medicament for the treatment of retinoid skin damage |
| 08/14/2002 | EP1230912A1 Use of at least one extract from a leguminous plant as an agent against pollution, trapping heavy metals |
| 08/14/2002 | EP1230367A1 19 human secreted proteins |
| 08/14/2002 | EP1230360A2 15 human secreted proteins |
| 08/14/2002 | EP1230349A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 08/14/2002 | EP1230342A1 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 08/14/2002 | EP1230263A1 A novel molecule |
| 08/14/2002 | EP1230255A1 25 human secreted proteins |
| 08/14/2002 | EP1230243A1 Poycyloalkylpurines as adenosine receptor antagonists |
| 08/14/2002 | EP1230236A1 Compound with growth hormone releasing properties |
| 08/14/2002 | EP1230232A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |